• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

δ1-皮质原酸对氯替泼诺依碳酸酯皮肤变白、药代动力学及稳定性的影响。

The effects of delta1-cortienic acid on skin blanching, pharmacokinetics and stability of loteprednol etabonate.

作者信息

Wu W M, Bodor E T, Howes J, Bodor N

机构信息

Center for Drug Discovery, College of Pharmacy, University of Florida, Gainesville 32610-0497, USA.

出版信息

Pharmazie. 2012 May;67(5):406-10.

PMID:22764572
Abstract

The effect of delta1-cortienic acid (delta1-CA) on human skin blanching activity of the soft corticosteroid, loteprednol etabonate (LE), has been studied. Ten volunteers had applied to their forearms a dose of LE ranging from 0.1 to 1 mM, or LE from 0.1 to 1 mM in combination with 2-times the concentration of delta1-CA (0.2 - 2mM). The results indicate that delta1-CA increased LE's effect on human vasoconstriction/skin blanching activity, both in the intensity and duration. This enhancing effect of delta1-CA was also observed in other blanching studies with other corticosteroids, such as hydrocortisone. The enhancement may occur through the displacement of LE bound to transcortin (also known as corticosteroid-binding globulin, or CBG) by delta1-CA as delta1-CA has a higher affinity for CBG than that for glucocorticoid receptor (GR), resulting in more free-LE to act on GR, and increased skin blanching. In rat studies, intravenous injection of delta1-CA (5-50 mg/kg) did not affect the pharmacokinetics of LE (5 mg/kg), indicating that delta1-CA is safe for combined use with LE. In stability studies, the presence of delta1-CA at the same concentrations as LE in aqueous suspension (0.1 and 0.2%) significantly increased the stability of LE. Thus, the combination of delta1-CA with LE serves an enhancing and stabilizing role while not impacting the pharmacokinetic properties of LE.

摘要

已对δ1-皮质烯酸(δ1-CA)对软质皮质类固醇卤倍他索丙酸酯(LE)的人体皮肤变白活性的影响进行了研究。十名志愿者在其前臂上涂抹了剂量范围为0.1至1 mM的LE,或0.1至1 mM的LE与两倍浓度的δ1-CA(0.2 - 2 mM)的组合。结果表明,δ1-CA在强度和持续时间上均增强了LE对人体血管收缩/皮肤变白活性的作用。在其他使用其他皮质类固醇(如氢化可的松)的皮肤变白研究中也观察到了δ1-CA的这种增强作用。这种增强作用可能是由于δ1-CA对转运皮质素(也称为皮质类固醇结合球蛋白,或CBG)的亲和力高于对糖皮质激素受体(GR)的亲和力,从而取代了与CBG结合的LE,导致更多的游离LE作用于GR,进而增强皮肤变白。在大鼠研究中,静脉注射δ1-CA(5 - 50 mg/kg)不影响LE(5 mg/kg)的药代动力学,表明δ1-CA与LE联合使用是安全的。在稳定性研究中,δ1-CA以与LE在水悬浮液中相同的浓度(0.1%和0.2%)存在时,显著提高了LE的稳定性。因此,δ1-CA与LE的组合起到了增强和稳定的作用,同时不影响LE的药代动力学特性。

相似文献

1
The effects of delta1-cortienic acid on skin blanching, pharmacokinetics and stability of loteprednol etabonate.δ1-皮质原酸对氯替泼诺依碳酸酯皮肤变白、药代动力学及稳定性的影响。
Pharmazie. 2012 May;67(5):406-10.
2
Pharmacokinetics and delta1-cortienic acid excretion after intravenous administration of prednisolone and loteprednol etabonate in rats.
Pharmazie. 2010 Jun;65(6):412-6.
3
Effect of cyclodextrins on the solubility and stability of a novel soft corticosteroid, loteprednol etabonate.环糊精对新型软质皮质类固醇洛替泼诺依碳酸酯的溶解度和稳定性的影响。
Pharmazie. 2000 Mar;55(3):206-9.
4
Pharmacokinetics of the sequential metabolites of loteprednol etabonate in rats.氯替泼诺酯在大鼠体内的系列代谢产物的药代动力学
J Pharm Pharmacol. 2008 Mar;60(3):291-7. doi: 10.1211/jpp.60.3.0003.
5
Soft drugs--10. Blanching activity and receptor binding affinity of a new type of glucocorticoid: loteprednol etabonate.软性毒品——10. 新型糖皮质激素氯替泼诺乙酯的皮肤变白活性和受体结合亲和力。
J Steroid Biochem Mol Biol. 1991 Feb;38(2):149-54. doi: 10.1016/0960-0760(91)90120-t.
6
Soft drugs. 19. Pharmacokinetics, metabolism and excretion of a novel soft corticosteroid, loteprednol etabonate, in rats.软性药物。19. 新型软性皮质类固醇药物氯替泼诺乙酯在大鼠体内的药代动力学、代谢及排泄情况
Pharm Res. 1995 Jun;12(6):875-9. doi: 10.1023/a:1016265105139.
7
Failure to detect systemic levels, and effects of loteprednol etabonate and its metabolite, PJ-91, following chronic ocular administration.长期眼部给药后未能检测到氯替泼诺及其代谢产物PJ - 91的全身水平及效应。
J Ocul Pharmacol Ther. 1998 Apr;14(2):153-8. doi: 10.1089/jop.1998.14.153.
8
Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.在健康志愿者中使用血管收缩试验评估局部用皮质类固醇活性。
Skin Pharmacol Physiol. 2007;20(3):133-40. doi: 10.1159/000098164. Epub 2006 Dec 21.
9
Metabolism, distribution, and transdermal permeation of a soft corticosteroid, loteprednol etabonate.一种软质皮质类固醇——氯替泼诺酯的代谢、分布及经皮渗透
Pharm Res. 1992 Oct;9(10):1275-8. doi: 10.1023/a:1015849132396.
10
Enhanced Activity of Topical Hydrocortisone by Competitive Binding of Corticosteroid-Binding Globulin.通过皮质类固醇结合球蛋白的竞争性结合增强局部氢化可的松的活性。
J Pharm Sci. 2016 Sep;105(9):2873-2878. doi: 10.1016/j.xphs.2016.03.028. Epub 2016 May 11.